🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Excellent News & Views on our paper out in Nature! We find alcohol metabolites attach to brain chromatin and affect learning! Berger Lab Penn Epigenetics Penn Medicine News Penn IDOM Friedman Brain Institute Mount Sinai Psychiatry check it out: nature.com/articles/s4225…

Congrats to @WellenLab, Irfan Asangani, and the Marmorstein lab for receiving an AFCRI Discovery Pilot Grant for a collaborative project entitled “Probing the metabolism-epigenetics link as a therapeutic target in prostate cancer” 🎉🎊🙌🏽

Interested in studying cancer epigenetics? Our new lab at UPenn has openings for postdoctoral scientists, students, and research assistants. check out lilingwanlab.com/open-positions for more information and how to apply.

excited to see our paper @nature today! We showed how gain-of-function mutations in chromatin reader ENL work to drive Wilms tumor. Fantastic collaborations with many great colleagues in Allis Wen Tjian + Darzacq Group Roeder @Muirlab Kentsis Research Group Li labs! nature.com/articles/s4158…

Epigenetic Regulation of Chromatin in Prostate Cancer. 𝘼𝙙𝙫 𝙀𝙭𝙥 𝙈𝙚𝙙 𝘽𝙞𝙤𝙡. ncbi.nlm.nih.gov/pubmed/31900918 #ProstateCancer Irfan Asangani bit.ly/2R4E5IL

Our chapter on PCa #metabolism. Part of a new book-"Prostate Cancer--Cellular & Genetic Mechanisms of Disease Development and Progression" edited by Scott Dehm +Don Tindall. Other great contributions from @AminaZoubeidi @drleighellis Daniel E Spratt Joaquin Mateo Irfan Asangani +more

Our paper is out, finally. Congratulations to first authors, Ritika Tiwari & Nishat Manzar, coauthors, collaborators Nallasivam Palanisamy Misha Beltran @AminaZoubeidi Francesca Khani, MD. Thanks to DBT/WT India Alliance for funding. Thanks Department of Biotechnology SERB IIT Kanpur nature.com/articles/s4146…

Excited to share our story "Cell Cycle Checkpoints Cooperate to Suppress DNA and RNA-Associated Molecular Pattern Recognition and Anti-Tumor Immune Responses". Really a team effort to make it happen Roger Greenberg Shane Harding Big thanks to our collaborators Andy Minn Irfan Asangani

Excited to share our new story on COVID-19. Our results have implications for understanding male bias in COVID-19 severity and mortality, and provide a strong rationale for androgen deprivation or anti-androgen therapy in men with SARS-CoV-2 infection. biorxiv.org/content/10.110…

Repurposing Cancer Drugs for COVID-19 cancerdiscovery.aacrjournals.org/content/early/…

Congratulations to Dr. Irfan Asangani, PhD Irfan Asangani of University of Pennsylvania Penn Epigenetics a recipient of our 2020-2022 Conquer Cancer Now Award #grant for their #CancerResearch project in #ProstateCancer #Immunology concernfoundation.org/donate-now Or TEXT CONCERN to 77948

Very excited to share our results about novel subtypes of metastatic castration-resistant prostate cancer ! Led by the awesome Fanying Tang. A true collaboration between Weill Cornell Medicine & @sloan_kettering and special thanks to Yu Chen ! biorxiv.org/content/10.110…

Just learned we received funding from National Cancer Institute #BeauBidenCancerMoonshot to study lineage plasticity in prostate cancer! Looking for talented post-docs to drive this project U-M Rogel Cancer Center! Please apply and re-tweet! PCF Science Society for Basic Urologic Research | SBUR Amer. Urol. Assn. @UmichCancBio University of Michigan

Excited to share our new study on Ewing Sarcoma (EwS). Here we discover stereociliary protein LOXHD1 as a novel oncogene and a potential tumor antigen in EwS. biorxiv.org/content/10.110… #sarcoma #immunotherapy #enhancer @GrunewaldLab @deng_qu bioRxiv

Our COVID-19 paper is out in iScience (Cell Press). Extremely proud of first authors @deng_qu reyaz ur rasool and Ram Natesan for their contribution to this critical pandemic-related work. #COVID19 #ACE2 #TMPRSS2 Penn Medicine Penn Epigenetics Prostate Cancer Foundation cell.com/iscience/fullt…

Many thanks to Irfan Asangani Cancer Discovery View: p300/CBP inhibition, CCS1477. A novel therapeutic approach for AR-addicted advanced prostate cancer. cancerdiscovery.aacrjournals.org/content/11/5/1…

If you are refusing to get vaccinated against COVID-19, maybe it's because you are getting your medical advice from news pundits, fearmongers, conspiracy theorists, and other deeply misinformed people, rather than from Medical Professionals.

The Irfan Asangani is looking for a postdoc in Cancer Epigenomics and Transcriptional Addiction - learn more about the position at the link below and come join a great team! bit.ly/2Sxm2ip

The University of Pennsylvania Penn Medicine Department of Cancer Biology Univ. of Pennsylvania Department of Cancer Biology seeks MD and/or PhD candidates for multiple tenure track positions at the Assistant Professor level. Applicants with expertise in any specific area of CBIO are encouraged. apply.interfolio.com/96881